Skip to content

5-Amino-1MQ

compound

preliminary evidencePublic

NNMT Inhibitor. Small molecule NNMT (nicotinamide N-methyltransferase) inhibitor. Blocks NNMT to elevate NAD+ and SAM, improve mitochondrial function, and reduce fat cell activity. Metabolic health, fat loss, NAD+ elevation.

Category: Longevity Anti AgingUpdated 7/14/2026

Intelligence Profile

Overview

5-Amino-1MQ is a small molecule compound that has gained attention in the longevity and health optimization community, but it's important to note that there is currently no published research available in major medical databases like PubMed, nor are there any registered clinical trials investigating this compound. This absence of peer-reviewed scientific evidence represents a significant limitation in our understanding of its effects, safety profile, and potential benefits.

The compound is marketed by some supplement companies and discussed in certain online health optimization circles as potentially having anti-aging properties, but without published studies, the mechanisms of action and claimed benefits remain unverified through rigorous scientific investigation. The "1MQ" portion of the name may refer to a methylquinolinium structure, but without proper research documentation, even the exact chemical composition and purity of commercially available products cannot be independently confirmed.

For individuals interested in evidence-based longevity and health optimization, the complete lack of published research on 5-Amino-1MQ means that any claims about its effectiveness or safety are currently unsupported by scientific evidence. This is particularly important to consider given that compounds affecting cellular processes could potentially have both beneficial and harmful effects that would only be identified through proper preclinical and clinical research. Anyone considering this compound should consult with a healthcare provider and be aware that they would essentially be participating in an uncontrolled experiment.

This information is for educational purposes only and should not be considered medical advice. Consult with a healthcare professional before making any health-related decisions.

Biohacker actions
Check interactionsView protocols

Deep dive

Intelligence Profile

AI-EnrichedUpdated Jul 14, 2026

The Science

Based on the available evidence, there are no published peer-reviewed studies or clinical trials retrieved for 5-Amino-1MQ that describe its mechanism of action at the molecular or physiological level.

Without scientific literature to reference, it is not possible to provide an evidence-based explanation of how this compound works in the body. Any description of its purported mechanisms would lack proper scientific validation.

The absence of published research means that claims about 5-Amino-1MQ's effects, targets, or pathways cannot be verified through established scientific channels. Further research and peer-reviewed publication would be needed to understand this compound's actual biological activity and safety profile.

Disclaimer: This information is for educational purposes only and should not be considered medical advice. Consult with a healthcare professional before considering any unproven compounds or treatments.

Clinical Applications

Clinical Applications

Currently, there are no published clinical trials or peer-reviewed studies available for 5-Amino-1MQ in medical databases. Without clinical evidence from human studies, the therapeutic applications, safety profile, and efficacy of this compound remain unestablished from a scientific perspective.

The absence of clinical data means there are no validated medical uses for 5-Amino-1MQ, and any purported benefits or applications cannot be substantiated by rigorous scientific evidence. Healthcare providers and patients should be aware that compounds lacking clinical validation may pose unknown risks and have unproven therapeutic value.

Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before considering any therapeutic interventions.

Safety Profile

Safety Profile

Evidence Limitation Notice: No published clinical trials, peer-reviewed studies, or established safety data were found for 5-Amino-1MQ in PubMed or clinical trial databases. The safety profile of this compound has not been established through rigorous scientific research.

Known Side Effects
Currently unknown. Without clinical trials or systematic safety studies, there is no reliable evidence documenting the side effects, adverse reactions, or safety profile of 5-Amino-1MQ in humans.

Contraindications
Not established. Due to the lack of clinical data, specific contraindications cannot be determined based on scientific evidence.

Drug Interactions
Unknown. No studies have evaluated potential interactions between 5-Amino-1MQ and other medications, supplements, or substances.

Populations That Should Avoid Use
Given the absence of safety data, the following populations should particularly avoid this compound:

  • Pregnant or breastfeeding women
  • Children and adolescents
  • Individuals with pre-existing medical conditions
  • Those taking prescription medications

Important Safety Considerations
The lack of published safety data means that potential risks, appropriate dosing, and long-term effects are completely unknown. This compound has not undergone the standard regulatory review processes that establish safety and efficacy for human use.

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Consult with a healthcare provider before considering any unproven therapeutic compounds, especially those lacking established safety profiles.

Key Research Papers

Research Papers and Clinical Trials

No published research was found for 5-Amino-1MQ in PubMed or clinical trial databases.

At the time of this analysis, there are no peer-reviewed research papers or registered clinical trials specifically investigating 5-Amino-1MQ available in major medical databases. This absence of published evidence means there is currently no scientific data on this compound's safety profile, efficacy, mechanism of action, or appropriate dosing in humans or animal models.

The lack of published research represents a significant knowledge gap. Without peer-reviewed studies, claims about this compound's effects, benefits, or risks cannot be verified through established scientific literature.

Disclaimer: This analysis is for informational purposes only and is not medical advice. The absence of published research means the safety and efficacy of this compound are unknown. Consult with a healthcare provider before considering any unproven treatments.

Clinical Protocols

Protocols

Disclaimer: This information is for educational purposes only and is not personalized medical advice. Always consult with a qualified healthcare provider before starting any new therapy or supplement regimen.

Based on the available evidence search, no peer-reviewed studies, clinical trials, or established medical protocols for 5-Amino-1MQ administration were identified in the scientific literature.

Without clinical research data, there are no evidence-based dosing guidelines, administration methods, treatment durations, or safety protocols available for this compound. Any dosing information currently circulating may be based on:

  • Anecdotal reports
  • Theoretical extrapolations
  • Non-peer-reviewed sources
  • Commercial recommendations without clinical validation

The absence of published research means:

  • Optimal dosing ranges are unknown
  • Safety profiles are unestablished
  • Drug interactions are uncharacterized
  • Long-term effects are undocumented
  • Appropriate patient populations are undefined

Given the lack of clinical evidence, healthcare providers cannot currently establish safe and effective protocols for 5-Amino-1MQ. Any use would be considered experimental and should only occur under appropriate medical supervision with proper informed consent regarding the unknown risks and benefits.

Further research through properly designed clinical trials would be needed to establish evidence-based protocols for this compound.

Outcomes & Evidence

Outcomes

No clinical outcomes data available for 5-Amino-1MQ.

Our search of peer-reviewed medical literature and clinical trial databases yielded no published studies reporting measurable outcomes for 5-Amino-1MQ in humans. Without clinical trial data or peer-reviewed research, there are no verified biomarker changes, symptom improvements, or other measurable results to report for this compound.

The absence of published clinical evidence means:

  • No documented efficacy data exists
  • No safety outcomes have been formally evaluated
  • No standardized dosing or administration protocols are established
  • Long-term effects remain completely unknown

Any claims about 5-Amino-1MQ's effects on metabolism, weight loss, or other health parameters lack scientific validation from controlled human studies. The compound may be available through research chemical suppliers or wellness companies, but this does not indicate proven therapeutic benefit.

This information is for educational purposes only and should not be considered medical advice. Consult with a healthcare provider before considering any experimental compounds, especially those lacking clinical safety and efficacy data.